Nationwide Fund Advisors’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Nationwide Fund Advisors’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,826	Closed	-$30K	–	3360
2016 Q1	$30K	Hold	2,826	–	–	﹤0.01%	3066
2015 Q4	$83K	Hold	2,826	–	–	﹤0.01%	2903
2015 Q3	$89K	Sell	2,826 -20,350	-88%	-$974K	﹤0.01%	2931
2015 Q2	$1.37M	Buy	23,176 +9,433	+69%	+$665K	0.01%	1671
2015 Q1	$1.47M	Buy	13,743 +10,992	+400%	+$1.05M	0.01%	1676
2014 Q4	$258K	Sell	2,751 -54	-2%	-$5.15K	﹤0.01%	2512
2014 Q3	$215K	Buy	2,805 +28	+1%	+$2.21K	﹤0.01%	2655
2014 Q2	$249K	Buy	2,777 +1,379	+99%	+$84.5K	﹤0.01%	2635
2014 Q1	$75K	Hold	1,398	–	–	﹤0.01%	2812
2013 Q4	$35K	Hold	1,398	–	–	﹤0.01%	3089
2013 Q3	$38K	Buy	1,398 +446	+47%	+$14.4K	﹤0.01%	3061
2013 Q2	$34K	Buy	+952	New	+$35.7K	﹤0.01%	3032

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Nationwide Fund Advisors's PTX Position: Q2 2016 in Review

Nationwide Fund Advisors sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 2,826 shares — an estimated $30K sold.

Nationwide Fund Advisors first reported a position in PTX in Q2 2013 and held it in 12 quarters. The position peaked at $1.47M in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Nationwide Fund Advisors reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 2,826 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $30K.
Nationwide Fund Advisors first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 12 quarters.
Nationwide Fund Advisors's Pernix Therapeutics Holdings, Inc. position peaked at $1.47M in Q1 2015.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Nationwide Fund Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.